Clinical Trials Logo
  1. Home
  2. Migraines
  3. NCT00483704

Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)

Migraines Clinical Trial

Official title:
A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Multiple Attacks Study to Compare the Efficacy and Safety of Oral MK-0974 With Placebo for the Acute Treatment of Migraine With or Without Aura

Clinical Trial Summary

The purpose of the study is to assess the safety and efficacy of telcagepant (MK-0974) in acute treatment of multiple migraine attacks with or without aura. Primary hypotheses of this study are that telcagepant is superior to placebo, as measured by the proportion of participants who have pain freedom, pain relief, pain freedom consistency, pain relief consistency, and absence of photophobia, phonophobia, and nausea at 2 hours post-dose.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00483704
Study type Interventional
Source Merck Sharp & Dohme Corp.
Contact
Status Completed
Phase Phase 3
Start date August 14, 2008
Completion date March 25, 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT01547494 - A Nutritional Intervention for Migraines N/A
Recruiting NCT06022848 - Quantitative Sensory Testing and Occipital Nerve Stimulator N/A
Completed NCT01699009 - A Nutritional Intervention for Migraines-2 N/A
Completed NCT01813669 - Integrative Coping Group for Children N/A
Completed NCT03844412 - Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments Phase 2
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Terminated NCT04201080 - A Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous TRV250 Phase 1
Completed NCT00727974 - Genetic Analysis of Children With Cyclic Vomiting Syndrome (CVS) and Migraines
Completed NCT00700128 - Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals N/A
Completed NCT00195754 - A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488. Phase 3
Completed NCT01807234 - Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine Phase 4
Completed NCT02748577 - Pain Processing in Adults With Migraines N/A
Completed NCT00753493 - Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients Phase 1
Completed NCT01337596 - A Study of LY2951742 in Healthy Volunteers Phase 1